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ABSTRACT
Purpose of the review: Reduced energy intake, resulting from favourable changes in eating
behaviour, is the predominant driver of weight-loss following bariatric surgery. Here we
review the most recent studies examining the impact of Roux-en-Y gastric bypass (RYGB) and
sleeve gastrectomy (SG), the two most common bariatric procedures, upon eating behaviour
and the suggested underlying biological mechanisms.
Recent findings: Following RYGB or SG most people report subjective changes in appetite,
taste and food preference, with decreased high-fat preference most commonly reported.
Objective post-surgery changes in taste and olfactory acuity occur. A new phenomenon,
‘meal-size aversion’, may contribute to reduced post-operative energy intake. Recent studies
provide evidence for peptide YY3-36, glucagon-like peptide-1, ghrelin, neurotensin and
oleoylethanolamide as mediators of post-operative eating behaviour changes. Factors
modulating these changes include sex, type 2 diabetes status, genetics and bariatric
procedure. New studies implicate central dopaminergic and opioid receptor signalling as key
neural mediators driving altered eating behaviour. Brain neuroimaging studies show that
obesity-associated changes in food-cue responses, brain connectivity and structural
abnormalities are normalised following bariatric surgery.
Summary: Understanding the biological mechanisms mediating the eating behaviour changes
engendered by bariatric surgery may lead to the development of novel therapeutic strategies
for people with obesity.
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Key points
 Reduced preference for high-fat foods is the most common self-reported change in
food preference following RYGB or SG. This finding is corroborated by objective
assessment of food preference changes in RYGB-operated rats with evidence for a
learnt response that is inconsistent with the development of conditioned taste
aversion.
 Gender, type 2 diabetes status, genetics and bariatric procedure type impact upon
eating behaviour changes following surgery.
 New mechanistic studies implicate PYY, GLP-1, ghrelin, NT and OEA as key gut-
derived factors that mediate changes in eating behaviour following RYGB or SG.
 Brain neuroimaging studies suggest that neuroplastic structural recovery and
restoration of functional connectivity as well as changes in neural responses to food
cues are normalised following bariatric surgery.
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INTRODUCTION
Bariatric surgery is the most effective treatment for people with severe obesity, leading to
marked sustained weight-loss together with reduced morbidity and mortality. Roux-en-Y
gastric bypass (RYGB) and sleeve gastrectomy (SG) are the most commonly performed
bariatric procedures undertaken globally(1). Weight-loss induced by lifestyle modification
engenders powerful compensatory biological changes leading to increased hunger, enhanced
neural responses to food-cues and heightened drive to consume energy-dense foods.
Together these changes contribute to the high rate of weight recidivism observed following
lifestyle intervention weight management programmes(2)*. In contrast following RYGB or SG,
despite marked weight-loss, hunger is reduced, neural responses to food-cues diminish, food
becomes less rewarding and a shift in preference away from high-fat, high-sugar foods is
reported enabling patients to adopt and maintain favourable changes in eating behaviour(3).
Post-operative changes in gut-derived factors such as gut hormones, nutrients, bile acids,
microbiome and neural signals acting peripherally and centrally upon homeostatic and
hedonic brain regions are suggested to mediate these post-surgical eating behaviour changes.
Weight-loss following RYGB or SG is highly variable with up to 20% of people experiencing
poor initial weight-loss or weight regain(4). Emerging evidence suggests a causal link between
favourable post-operative eating behaviour changes and subsequent weight-loss(5)*.
Importantly, whilst weight-loss independent metabolic improvements occur immediately
post-surgery, longer-term health improvements are related to the degree of sustained
weight-loss achieved, thus highlighting the need to maximise post-surgery weight-loss(6,7). A
greater understanding of the impact of RYGB and SG upon key determinants of eating
behaviour, namely appetite, taste, olfaction, food preference or aversion, food-reward and
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more importantly the biological mechanisms mediating these changes, may lead to the
development of novel therapeutic strategies for people with overweight or obesity.
This review summarises recent data examining the impact of RYGB and SG upon the key
determinants of eating behaviour, the differences in response following these two
procedures, and the purported underlying biological mechanisms involved.
NEW STUDIES EXAMINING THE IMPACT OF BARIATRIC SURGERY UPON SUBJECTIVE AND
OBJECTIVE DETERMINANTS OF EATING BEHAVIOUR
Reduced energy intake due to a decreased consumption of energy-dense food and beverages
is suggested to contribute to long-term weight reduction following RYGB(3) and SG(8)*. The
factors determining nutrient selection and subsequent ingestion are complex and include
taste, olfaction, subjective pleasure, adverse post-ingestive gastrointestinal effects and
higher executive function.
Most studies examining food preference changes relate to RYGB and have utilised self-report
questionnaires. Collectively these studies suggest that post-RYGB intake of high-fat, high-
sugar, unhealthy foods is reduced whilst intake of healthy food items is increased(9)*.
Recently, however, studies have begun to examine food preference changes post-SG. Van
Vuuren et al., in a prospective study of 106 individuals undergoing SG, reported that most
participants experienced a change in the taste, desire and enjoyment of flavours in the first 6
months post-SG(10)*. Increased intensity of sweet and fatty tastes coupled with decreased
enjoyment and desire for these were the most consistent findings. Gero and colleagues also
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prospectively assessed the desire to consume different tastes (sweet, sour, bitter, spicy, salt,
fatty and umami) in 100 participants pre-SG and 6 days and 6 months post-SG using food
photographs. Preference for all tastes decreased early post-SG with greatest decline observed
for sweet and fatty foods(11)*. However, a 2-year prospective study in 30 SG patients
suggests these changes in sweet preference may be short-lived; whilst the majority of
patients reported changes for sweet and fat tastes at 6 months post-surgery, by 2 years only
23% reported reduced interest in sweet(8)*. The accuracy of self-reported food preferences
has, however, been questioned. A recent study directly measured food intake during an ad
libutum buffet and food preferences using photographs in 31 RYGB and 10 SG patients pre-
operatively and 6 months post-operatively(12)**. Energy intake following surgery was halved
but the relative intake from high/low fat, sweet and savoury groups remained unchanged,
suggesting that reduced meal size drives reduced energy intake at this time. Interestingly, in
the accompanying picture preference test individuals preferentially choose low-fat savoury
food post-surgery. The reason for this disparity between self-reported preference and direct
measurement is unclear but highlights the need for objective eating behaviour assessments.
Objective changes in food preference post-RYGB have been shown in rodents using nutritive
stimuli such as sucrose solution and intra-lipid. These findings have now been extended to
more complex diets. After an 18-day recovery period from sham or RYGB surgery, rats were
studied with 8-days free access to 4 semisolid foods of differing fat and sugar concentrations,
alongside standard chow and water(13)**. Post-RYGB rats consumed fewer total calories
than sham-operated rats, whilst a significant decrease in the percentage of calories from
sugar-fat whip (high-fat/high-sugar) led to an overall reduction in relative fat intake, increase
in non-sugar carbohydrate and a marginal increase in protein. Interestingly these changes
were progressive, reaching significance from day 4 onwards, thus suggesting a learned
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response to the post-ingestive consequences of different diets. However, RYGB rats, like sham
rats, continued to consume the majority of their calories from the high-fat/high-sugar option.
Evidently, RYGB rats still found this food item palatable, a finding which is inconsistent with
the development of a conditioned taste aversion. Moreover, new evidence from a study in
rats without bariatric surgery, in which meal intake exceeding a pre-defined size threshold
was coupled with lithium chloride-induced gastric illness, suggested the existence of a novel
phenomenon, ‘conditioned meal-size’, as opposed to conditioned taste aversion. Here, the
adverse consequence of consuming large meals was also learnt(14)**. This phenomenon may
be one of the mechanisms by which bariatric surgery leads to reduced meal size and induces
weight-loss.
Two new cross-sectional studies, one focused predominately on patients in the first post-
operative year(15)* (104 RYGB, 50 SG) and the other examining patients 6 months to 5 years
post-surgery(16)* (98 RYGB, 155 SG), utilised the same questionnaire to compare the impact
of RYGB and SG upon self-reported changes in appetite, taste, olfaction and food aversion
post-operatively and examined potential association with weight-loss. Both studies found the
majority of patients following both procedures reported reduced appetite, new food
aversions and changes in taste, most commonly for sweet and fat with no differences
between RYGB and SG groups. These studies differed in their findings relating to self-reported
olfactory changes, being more prevalent post-SG (52%) compared to post-RYGB (34%) in the
early post-operative period(15)* but less common post-SG (28%) than post-RYGB (41%) in the
long-term(16)*. Of note, the prevalence of appetite changes also decreased with time post-
SG but not post-RYGB. Interestingly, gender differences were noted in the SG group, with
taste and smell changes being more prevalent in female patients than male. Furthermore,
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men post-SG lost significantly less weight compared to men post-RYGB whereas weight loss
was similar in women(16)*.
Recently two longitudinal studies, albeit with small numbers, have objectively examined early
post-operative changes in gustatory sensitivity as compared to pre-surgery(17*,18*).
Sensitivity to all tastants evaluated (sweet, sour, bitter and salty) increased post-surgery(17)*.
Comparison between RYGB and SG groups revealed a higher sourness threshold post-RYGB
compared to post-SG, with no differences in either the other taste thresholds or sweetness
acceptability(18)*. Objective, longitudinal assessments of olfactory function alone also report
improved function in the early post-surgery stage(19,20).
Taken together these new studies suggest that post-surgery change in appetite, taste and
smell may contribute to food preference changes following RYGB and SG, whilst conditioned
meal-size aversion may contribute to reduced meal-size. However, large longitudinal studies
combining subjective and objective measures of energy intake, food preference, taste and
olfaction, with a focus on gender and procedural differences are warranted. Furthermore, in
order to evaluate the role of adiposity and weight-loss per se in mediating taste and olfactory
changes, additional control groups of normal-weight subjects, obese weight-stable subjects
and weight-matched participants who lose weight through dietary restriction also need to be
evaluated.
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NEW INSIGHTS INTO BIOLOGICAL MECHANISMS UNDERLYING EATING BEHAVIOUR
FOLLOWING RYGB AND SG
The biological mediators underlying the marked and sustained weight-loss observed following
RYGB and SG remain incompletely understood. However, there is general agreement that
altered nutrient and/or biliary flow engenders changes in a multitude of gut-derived signals.
In concert, these modulate brain regions regulating food intake, reward-processing and
executive function, ultimately leading to favourable changes in eating behaviour and reduced
energy intake.
New evidence supporting a causal role for the anorectic gut hormones glucagon-like peptide-
1 (GLP-1) and peptide YY3-36 (PYY) in reducing energy intake post-RYGB has emerged. In
individuals post-RYGB, combined GLP-1 receptor antagonism and di-peptidyl-peptidase-4
(DPP-4) inhibition, the enzyme required to generate PYY, led to a 20% increase in energy
intake(21)**. Isolated GLP-1 receptor antagonism or DPP-4 inhibition had no demonstrable
effect, conceivably due to a compensatory rise in the unblocked hormone. Functional
neuroimaging studies have shown that altering circulating gut hormone levels and/or
receptor activation modulates neural response within homeostatic, hedonic and executive
function regions in humans(22). Similarly, brain regions exhibit changes in neural activity post-
RYGB coupled with reduced appetitive behaviour for energy-dense foods leading to the
suggestion that gut hormones mediate these changes. Evidence in support of this hypothesis
comes from a study of RYGB-operated individuals that coupled a functional magnetic
resonance (fMRI) imaging food picture evaluation task with blockage of gut hormone release
via administration of a somatostatin analogue. Reduction in circulating PYY levels positively
correlated with increase in brain reward system activity, with a similar trend observed for
GLP-1(23)**. Moreover, a prospective, longitudinal fMRI study in RYGB and SG candidates
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with weight-stable controls implicated post-operative suppression of the orexigenic
hormone, ghrelin, as a key mediator of changes in liking for highly-palatable foods post-
surgery. Proposed mechanisms include ghrelin-mediated modulation of dopaminergic neuron
activity in the ventral tegmental area (VTA) (Table 1), a central site for reward
processing(24)*. Interestingly, a study in RYGB-operated rats suggests that changes in ghrelin-
mediated signalling in VTA dopaminergic reward neurons may underlie the increased
incidence of alcohol-dependence observed following RYGB(25)*.
Neurotensin (NT), which is co-expressed in enteroendocrine cells with GLP-1 and PYY(26), has
also been proposed to contribute to eating behaviour changes post-RYGB. Peripheral NT
administration reduces food and sucrose intake in rodents with hypothalamic, brainstem and
vagal sites of action being implicated from mechanistic studies(27)**. Circulating NT levels
increase after RYGB and NT receptor blockade in post-RYGB rats transiently increased food
intake. Importantly, combined peripheral administration of NT with GLP-1 or PYY
synergistically reduced intake of palatable food and inhibited gastric emptying(28)**. These
findings argue that a therapeutic approach targeting two or more gut hormones is likely to be
more efficacious. Indeed, Tan and colleagues have recently shown that acute continuous
subcutaneous infusion of GLP-1, PYY and oxyntomodulin, replicating the postprandial levels
observed following RYGB, reduced mean energy intake of obese volunteers by approximately
one third(29)**. An alternative approach is to stimulate endogenous hormone secretion akin
to the physiological response post-RYGB where L-cell stimulation through bile acids is
proposed to contribute to increased circulating gut hormone levels. Further evidence in
support of this notion comes from the recent finding that oral administration of primary bile
acid chenodeoxycholic acid (CDCA) to RYGB-operated participants increased plasma
concentrations of GLP-1, PYY and NT in the absence of nutrients(30)*. Moreover, these
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findings suggest that oral CDCA may represent a therapeutic strategy to enhance gut
hormone levels in people with poor weight loss post-RYGB.
A complex interaction exists between bile acids, the gut microbiome and gut hormone
secretion from enteroendocrine cells(31). A new study has identified a novel link between
intestinal microbiota and circulating levels of metabolites purported to regulate energy
homeostasis(32). Moreover, following SG, weight loss was associated with altered microbiota
and circulating metabolite levels. Additional studies are needed to establish the directionality
of this relationship.
A reduced preference for and intake of high-fat foods is a consistent finding following RYGB
and SG. Understanding the post-surgery drivers underlying these changes is therefore a key
priority. New studies undertaken in RYGB-operated rats by Hankir et al., provide novel insights
into the gut-brain pathways mediating this reduced fat preference(33*,34*). In RYGB-
operated rats they found circulating levels of oleoylethanolamide (OEA), an anorectic lipid
mediator synthesised by enterocytes from dietary oleic, were increased post-meal with high-
fat feeding(33)*. In subsequent mechanistic studies they identified that OEA acts via vagal
afferents to modulate striatal dopaminergic signalling and reduce postoperative high-fat
consumption (Table 1). Next, in light of the fact that the brain μ-opioid receptor (MOR) system 
is implicated in regulating fat consumption, they examined fat preference, MOR availability
and MOR protein expression in RYGB-operated rats who were in the weight-loss maintenance
phase compared to sham-operated, calorically-restricted weight-matched rats(34)*. High-fat
intake was reduced in RYGB-operated rats and associated with widespread reduction in MOR
availability particularly in the striatum (Table 1). Levels of MOR protein were also reduced in
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the striatum and prefrontal cortex compared to weight-matched rats. The authors concluded
that the reduced fat preference following RYGB may be due to reduced brain MOR signalling.
Brain neuroimaging studies have identified that obesity is not only associated with altered
food-cue responses but also structural abnormalities(35,36) and changes in resting-state
connectivity in brain regions involved in energy regulation, reward and motivation(37).
Neuroimaging studies have shown that these obesity-associated neural responses to food
cues are ‘normalised’ following bariatric surgery(23**,38–40). More excitingly, emerging data
suggest that both neuroplastic structural recovery and restoration of functional connectivity
occur following RYGB and SG(41**,42**). Table 2 summarises key findings from recent
neuroimaging studies.
EVIDENCE FOR INTERPLAY BETWEEN GENETICS, EATING BEHAVIOUR AND WEIGHT-LOSS
Weight-loss following RYGB and SG is highly variable with genetics estimated to contribute
up to 70% of this variability(43). Candidate-gene based approaches and hypothesis-free
genome-wide association studies (GWAS) have been used to identify the genes underlying
this variability with limited success, in part due to low sample sizes(44–48). Poor post-surgery
weight loss can ensue from high-allelic burden of such SNPs(47). However, even the marked
hyperphagia seen in the complex genetic condition Prader-Willi syndrome might be
effectively altered by bariatric surgery; Magel2 knockout mice, an animal model of this
condition, have shown comparable fat-mass loss and reduced fat intake to wild-type carriers
after SG(49)**. Future large GWAS coupled with detailed eating behaviour phenotyping will
hopefully allow informed selection of both surgical candidates and surgical procedures but
also identify novel pathways that can be targeted non-surgically to modulate eating
behaviour.
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CONCLUSION
Changes in taste, olfaction, food preference and food reward following RYGB and SG, drive
favourable changes in eating behaviour and reduced energy intake. Moreover, obesity-
associated neural changes are normalised post-operatively. Changes in gut-derived factors
altered as a consequence of anatomical gastrointestinal tract rearrangement acting in concert
underlie these changes (Figure 1). Emerging data suggest nuanced differences in the impact
of RYGB and SG upon the determinants of eating behaviour that most likely reflect their
differential impact upon gut-derived hormones. Future longitudinal studies, in people
undergoing RYGB or SG compared to people losing weight through non-surgical means, with
subjective and objective assessments of appetite, taste, olfaction, food preference and food
reward together with mechanistic studies are needed to fully elucidate how bariatric surgery
alters eating behaviour. A greater understanding of the mechanisms involved and interaction
with a person’s genetics and pre-surgery phenotype will allow surgical procedure choice to
be tailored to the individual and facilitate discovery of novel non-surgical treatments for
people with obesity.
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Figure 1: Schematic diagram illustrating recent findings in gut-brain signalling pathways
proposed to mediate eating behaviour changes after bariatric surgery.
Anatomical rearrangement of the gastrointestinal tract leads to reduced circulating levels of
ghrelin and increased levels of anorectic gut hormones. Oral intake of the primary bile acid,
chenodeoxycholic acid, enhances L-cell release of NT, GLP-1 and PYY even in the absence of
luminal nutrients. GLP-1 and PYY act in concert to inhibit energy intake. NT acts synergistically
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with GLP-1 and PYY to reduce energy intake and delay gastric emptying. Cross-talk between
gut microbiota and bile-acids, in addition to new links between microbiota and circulating
metabolites involved in energy homeostasis, may play a role. Pathways involving key brain
reward centres are proposed to mediate reduced fat preference and intake post-surgery;
ghrelin modulates dopaminergic neuron activity in the VTA, OEA acts via vagal afferents to
reduce striatal D1R signalling, and reduced MOR signalling in the striatum and prefrontal
cortex have been found. Neuroimaging studies suggest that neuroplastic structural recovery,
restoration of functional connectivity and normalisation of brain responses to food cues also
occur. These gut-brain signalling pathways manifest in increased taste and olfactory
sensitivity, meal-size aversions and reduced hunger. Whether weight loss per se leads to
changed eating behaviour or whether the pathways described occur directly due to surgical
intervention, remains unclear.
BA, bile acid; CNS, central nervous system; D1R, dopamine 1 receptor; GI, gastrointestinal;
GLP-1, glucagon-like peptide-1; MOR, μ opioid receptor; NT, neurotensin; OEA, 
oleoylethanolamide, PPARα, peroxisome proliferator-activated receptor alpha; PYY, peptide 
YY3-36; VTA, ventral tegmental area.
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Alcohol further suppresses acyl-ghrelin
level after RYGB. Alcohol dependent
behaviours in RYGB rats appear
independently to post-surgery decrease
in ghrelin and GHSR activity.
Blocking GHSR does not decrease
VTA dopaminergic neuron activity.
Changes in GHSR activity








RYGB reduces OEA production.
Vagal-driven increase in striatal
dopamine release. RYGB upregulates
striatal D1R expression, specifically
under high-fat diet conditions.
Dopamine signalling
through D1R contributes to








RYGB rats had suppressed high-fat
diet intake and preference, reduced
MOR availability and downregulation




fat appetite after RYGB.
Table 1: Recent findings in gut-brain signalling in the control of eating behaviour
D1R, dopamine 1 receptor; GHSR, growth hormone secretagogue receptor; MOR, µ-opioid
receptor; OEA, oleoylethanolamide; VTA, ventral tegmental area.
Table 2: Summary of findings from recent neuroimaging studies
RYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy; fMRI, function magnetic resonance
imaging; PET, positron emission tomography; m, month; w, week; T2DM, type 2 diabetes
mellitus; BOLD, blood oxygen level dependent; HCF, high-calorie food; LCF, low-calorie food;
VTA, ventral tegmental area; OFC, orbitofrontal cortex.
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- Gut hormone levels
- Food appeal and
reward rating to visual
stimuli




PYY, insulin and FGF19 rise after
RYGB, less so after Band.
Octreotide associated with lower
appeal of palatable food.
Octreotide reduced BOLD signal in
reward centres upon visual cues of
palatable food.
Brain-hedonic responses
after RYGB may be
directly mediated by the
elevation in anorectic



















- Likert scale (11-point)
rating of palatability of
visual stimulus.
- BOLD activation in
brain reward regions.
- Fasting ghrelin level.
Baseline liking of HCF higher than
LCF in all 3 groups. At 6m, RYGB
and SG lower liking score of HCF.
Reduced liking of HCF relative to
LCF: more after RYGB than SG.
Post-RYGB, increased BOLD
response to LCF and reduced
response to HCF in VTA. No
change in SG or controls.
VTA is a critical site for
modulating post-
surgical change in liking


















- Subjective reports of
taste preference.
- Sensory and reward
brain area activation.
In response to sweet taste,
significant decrease in brain reward
centre activation in both RYGB
and control groups. In response
salty taste, RYGB increased
activation in primary gustatory
cortex and reward centres.
fMRI-detected brain
activation changes to
palatable tastes do not
always correlate with
subjective reports.
Salt taste rather than


















- Likert scale (5-point)
for wanting and liking
of visual stimulus
- BOLD activation of
brain regions.
- Hunger rating
- Three Factor Eating
Questionnaire
- Power of Food Scale
- Beck Depression
Inventory
RYGB: Lower liking and wanting
ratings; equivalent mood and
hunger scores; lower scores in
eating behaviour-related traits.
RYGB: higher activation in visual,
frontal control, somatosensory,
motor, memory-related and
gustatory regions. Lower activation
in inhibition and reward regions
and precuneus.
Greater HbA1c reduction sig.
associated with higher OFC
activity for food reward.
Differences in food
reward-associated brain




















- Ad libitum food
consumption
- FDG uptake in brain
regions
Somatostatin after RYGB gave
higher overall fullness and food-
induced sickness, lower ad-libitum
consumption. Increased activation
hypothalamus, pituitary, left medial
orbital cortex. Decreased activation
right dorsolateral frontal cortex.
Gut peptide alterations
after RYGB may



























behaviour and food saliency pre-
surgery vs. controls, but weakens
over time post-surgery. At 12m,
changes in cognitive control over
eating. Early reduced connectivity
between emotional control and
social cognition regions post-
surgery, but increases by 12m. Pre-





in cognitive control of
eating could play major
role in success of























Decreased FA, GM/WM density
and increased MD in brain regions
for food intake (caudate,
orbitofrontal cortex, body and genu
of corpus callosum) and cognitive-
emotion regulation (inferior frontal
gyrus, hippocampus, insula,
external capsule) after SG
Acute neuroplastic
structural recovery
attributable to SG which
may mediate the
behavioural effects of
SG.
